用于心血管预防的秋水仙碱：混乱中的明晰 - Suppr

Colchicine for Cardiovascular Prevention: Clarity Amidst the Confusion.

作者信息

Imazio Massimo

机构信息

Department of Medicine, University of Udine, 33100, Udine, Italy.

Cardiothoracic Department, University Hospital Santa Maria della Misericordia, ASUFC, Piazzale Santa Maria della Misericordia 15, 33100, Udine, Italy.

出版信息

Am J Cardiovasc Drugs. 2025 Sep 1. doi: 10.1007/s40256-025-00754-9.

DOI:10.1007/s40256-025-00754-9

PMID:40889094

Abstract

摘要

相似文献

Colchicine for Cardiovascular Prevention: Clarity Amidst the Confusion.

Am J Cardiovasc Drugs. 2025 Sep 1. doi: 10.1007/s40256-025-00754-9.

Colchicine for the primary prevention of cardiovascular events.

Cochrane Database Syst Rev. 2025 Feb 10;2(2):CD015003. doi: 10.1002/14651858.CD015003.pub2.

Long-term trials of colchicine for secondary prevention of vascular events: a meta-analysis.

Eur Heart J. 2025 Jul 7;46(26):2552-2563. doi: 10.1093/eurheartj/ehaf174.

Colchicine for prevention of major adverse cardiovascular events: a meta-analysis of randomized clinical trials.

J Cardiovasc Med (Hagerstown). 2025 Jul 1;26(7):359-368. doi: 10.2459/JCM.0000000000001744. Epub 2025 Jun 5.

Colchicine for secondary prevention of vascular events: a meta-analysis of trials.

Eur Heart J. 2025 Jul 7;46(26):2564-2575. doi: 10.1093/eurheartj/ehaf210.

Colchicine for cardiovascular medicine: a systematic review and meta-analysis.

Future Cardiol. 2022 Aug;18(8):647-659. doi: 10.2217/fca-2020-0206. Epub 2022 Jul 5.

Cardiovascular Benefit of Colchicine in Relation to Baseline Risk: A Secondary Analysis of the LoDoCo2 Trial.

J Am Heart Assoc. 2025 May 20;14(10):e038687. doi: 10.1161/JAHA.124.038687. Epub 2025 May 15.

The efficacy of colchicine compared to placebo for preventing ischemic stroke among individuals with established atherosclerotic cardiovascular diseases: a systematic review and meta-analysis.

Scand Cardiovasc J. 2025 Dec;59(1):2441112. doi: 10.1080/14017431.2024.2441112. Epub 2024 Dec 21.

Colchicine for the Secondary Prevention of Cardiovascular Diseases: A Cumulative-Dose Meta-analysis of Randomized Controlled Trials including 31,397 Subjects Worldwide.

Am J Cardiovasc Drugs. 2025 Sep 1. doi: 10.1007/s40256-025-00743-y.

Colchicine for prevention of cardiovascular events.

Cochrane Database Syst Rev. 2016 Jan 27;2016(1):CD011047. doi: 10.1002/14651858.CD011047.pub2.

本文引用的文献

Comparative Efficacy of Pharmacological Interventions for Heart Failure with Reduced Ejection Fraction Between Asian and White Patients: A Meta-analysis of Randomized Controlled Trials.

Am J Cardiovasc Drugs. 2025 Jul 11. doi: 10.1007/s40256-025-00745-w.

Colchicine for prevention of major adverse cardiovascular events: a meta-analysis of randomized clinical trials.

J Cardiovasc Med (Hagerstown). 2025 Jul 1;26(7):359-368. doi: 10.2459/JCM.0000000000001744. Epub 2025 Jun 5.

Colchicine for Secondary Prevention in Established ASCVD: A Systematic Review and Meta-Analysis.

Eur J Prev Cardiol. 2025 Jun 12. doi: 10.1093/eurjpc/zwaf332.

Colchicine in acute coronary syndromes: a systematic review and meta-analysis of randomised controlled trials.

Heart. 2025 May 16. doi: 10.1136/heartjnl-2025-325826.

The efficacy and safety of low dose colchicine in atherosclerotic cardiovascular disease - A systematic review and meta-analysis.

Eur J Prev Cardiol. 2025 May 16. doi: 10.1093/eurjpc/zwaf302.

Colchicine for secondary prevention of vascular events: a meta-analysis of trials.

Eur Heart J. 2025 Jul 7;46(26):2564-2575. doi: 10.1093/eurheartj/ehaf210.

Colchicine in acute coronary syndromes: the present and the possible future.

Nat Rev Cardiol. 2025 Apr;22(4):215-216. doi: 10.1038/s41569-025-01124-3.

Long-term colchicine for the prevention of vascular recurrent events in non-cardioembolic stroke (CONVINCE): a randomised controlled trial.

Lancet. 2024 Jul 13;404(10448):125-133. doi: 10.1016/S0140-6736(24)00968-1. Epub 2024 Jun 7.

Colchicine in Patients with Chronic Coronary Disease.

N Engl J Med. 2020 Nov 5;383(19):1838-1847. doi: 10.1056/NEJMoa2021372. Epub 2020 Aug 31.

Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction.

N Engl J Med. 2019 Dec 26;381(26):2497-2505. doi: 10.1056/NEJMoa1912388. Epub 2019 Nov 16.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Colchicine for Cardiovascular Prevention: Clarity Amidst the Confusion.

作者信息

Imazio Massimo

机构信息

Department of Medicine, University of Udine, 33100, Udine, Italy.

Cardiothoracic Department, University Hospital Santa Maria della Misericordia, ASUFC, Piazzale Santa Maria della Misericordia 15, 33100, Udine, Italy.

出版信息

Am J Cardiovasc Drugs. 2025 Sep 1. doi: 10.1007/s40256-025-00754-9.

DOI:10.1007/s40256-025-00754-9

PMID:40889094

Abstract

摘要

相似文献

Colchicine for Cardiovascular Prevention: Clarity Amidst the Confusion.

Am J Cardiovasc Drugs. 2025 Sep 1. doi: 10.1007/s40256-025-00754-9.

Colchicine for the primary prevention of cardiovascular events.

Cochrane Database Syst Rev. 2025 Feb 10;2(2):CD015003. doi: 10.1002/14651858.CD015003.pub2.

Long-term trials of colchicine for secondary prevention of vascular events: a meta-analysis.

Eur Heart J. 2025 Jul 7;46(26):2552-2563. doi: 10.1093/eurheartj/ehaf174.

Colchicine for prevention of major adverse cardiovascular events: a meta-analysis of randomized clinical trials.

J Cardiovasc Med (Hagerstown). 2025 Jul 1;26(7):359-368. doi: 10.2459/JCM.0000000000001744. Epub 2025 Jun 5.

Colchicine for secondary prevention of vascular events: a meta-analysis of trials.

Eur Heart J. 2025 Jul 7;46(26):2564-2575. doi: 10.1093/eurheartj/ehaf210.

Colchicine for cardiovascular medicine: a systematic review and meta-analysis.

Future Cardiol. 2022 Aug;18(8):647-659. doi: 10.2217/fca-2020-0206. Epub 2022 Jul 5.

Cardiovascular Benefit of Colchicine in Relation to Baseline Risk: A Secondary Analysis of the LoDoCo2 Trial.

J Am Heart Assoc. 2025 May 20;14(10):e038687. doi: 10.1161/JAHA.124.038687. Epub 2025 May 15.

The efficacy of colchicine compared to placebo for preventing ischemic stroke among individuals with established atherosclerotic cardiovascular diseases: a systematic review and meta-analysis.

Scand Cardiovasc J. 2025 Dec;59(1):2441112. doi: 10.1080/14017431.2024.2441112. Epub 2024 Dec 21.

Colchicine for the Secondary Prevention of Cardiovascular Diseases: A Cumulative-Dose Meta-analysis of Randomized Controlled Trials including 31,397 Subjects Worldwide.

Am J Cardiovasc Drugs. 2025 Sep 1. doi: 10.1007/s40256-025-00743-y.

Colchicine for prevention of cardiovascular events.

Cochrane Database Syst Rev. 2016 Jan 27;2016(1):CD011047. doi: 10.1002/14651858.CD011047.pub2.

本文引用的文献

Comparative Efficacy of Pharmacological Interventions for Heart Failure with Reduced Ejection Fraction Between Asian and White Patients: A Meta-analysis of Randomized Controlled Trials.

Am J Cardiovasc Drugs. 2025 Jul 11. doi: 10.1007/s40256-025-00745-w.

Colchicine for prevention of major adverse cardiovascular events: a meta-analysis of randomized clinical trials.

J Cardiovasc Med (Hagerstown). 2025 Jul 1;26(7):359-368. doi: 10.2459/JCM.0000000000001744. Epub 2025 Jun 5.

Colchicine for Secondary Prevention in Established ASCVD: A Systematic Review and Meta-Analysis.

Eur J Prev Cardiol. 2025 Jun 12. doi: 10.1093/eurjpc/zwaf332.

Colchicine in acute coronary syndromes: a systematic review and meta-analysis of randomised controlled trials.

Heart. 2025 May 16. doi: 10.1136/heartjnl-2025-325826.

The efficacy and safety of low dose colchicine in atherosclerotic cardiovascular disease - A systematic review and meta-analysis.

Eur J Prev Cardiol. 2025 May 16. doi: 10.1093/eurjpc/zwaf302.

Colchicine for secondary prevention of vascular events: a meta-analysis of trials.

Eur Heart J. 2025 Jul 7;46(26):2564-2575. doi: 10.1093/eurheartj/ehaf210.

Colchicine in acute coronary syndromes: the present and the possible future.

Nat Rev Cardiol. 2025 Apr;22(4):215-216. doi: 10.1038/s41569-025-01124-3.

Long-term colchicine for the prevention of vascular recurrent events in non-cardioembolic stroke (CONVINCE): a randomised controlled trial.

Lancet. 2024 Jul 13;404(10448):125-133. doi: 10.1016/S0140-6736(24)00968-1. Epub 2024 Jun 7.

Colchicine in Patients with Chronic Coronary Disease.

N Engl J Med. 2020 Nov 5;383(19):1838-1847. doi: 10.1056/NEJMoa2021372. Epub 2020 Aug 31.

Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction.

N Engl J Med. 2019 Dec 26;381(26):2497-2505. doi: 10.1056/NEJMoa1912388. Epub 2019 Nov 16.

Colchicine for Cardiovascular Prevention: Clarity Amidst the Confusion.

作者信息

机构信息

出版信息

相似文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

Colchicine for Cardiovascular Prevention: Clarity Amidst the Confusion.

作者信息

机构信息

出版信息

相似文献

本文引用的文献